The Center for Pediatric-Onset Demyelinating Disease is one of six Pediatric Multiple Sclerosis (MS) Centers of Excellence in the country designated and funded in 2006 by the National Multiple Sclerosis Society. It was established by a grant awarded to the University of Alabama at Birmingham, Department of Pediatrics, and operates at Children's of Alabama. CPODD strives toward the achievement of three important goals:
- Clinical Excellence: To provide comprehensive multi-disciplinary care for children and teens with MS and other CNS demyelinating diseases.
- Education: To provide up-to-date, accurate information about MS and related disorders to patients and families, schools, health care providers, and the public at large.
- Research: To build a multi-ethnic cohort of children and teens from the Southeast with demyelinating disease and carefully characterize this patient population with respect to clinical presentation, neuro-imaging and laboratory findings, treatment regimen, cognitive functioning, quality of life measures and long-term functional outcome.
1 Person | 0 Impacts | 0 Hours